Cary, NC, United States of America

Jessymol Mathew


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Cary, NC (US) (2005 - 2008)
  • Raleigh, NC (US) (2008)

Company Filing History:


Years Active: 2005-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jessymol Mathew from Cary, NC

Introduction

Jessymol Mathew is an accomplished inventor based in Cary, NC, with a focus on cutting-edge biomedical applications. With three patents to her name, she has significantly contributed to the fields of diagnostics and therapeutics, particularly in the development of neurokinin antagonists.

Latest Patents

Jessymol Mathew's latest patents include groundbreaking work in helix mimetics and reverse-turn mimetics. Her patent on helix mimetics encompasses compounds that mimic the secondary structure of helical regions in biologically active peptides and proteins. These compounds have wide-ranging applications, especially in their use as diagnostic and therapeutic agents. They are specifically designed to act as neurokinin antagonists. The patent also outlines libraries of these compounds and methods for screening them to identify biologically active members.

Her reverse-turn mimetics patent details similar innovative compounds, focusing on their structure and application as diagnostic and therapeutic agents as well. Like her first patent, these compounds also function as neurokinin antagonists, with the documentation providing insight into libraries containing these mimetics and methods to screen for biologically active substances.

Career Highlights

Jessymol Mathew currently works for Myriad Genetics, Inc., where she applies her expertise in biochemistry and molecular biology to her research and development initiatives. Her innovative work in designing compounds that serve as potential therapeutic agents places her at the forefront of her field.

Collaborations

Throughout her career, Jessymol has collaborated with notable colleagues, including Vincent Huber and Jan Urban. These partnerships have facilitated a rich exchange of ideas and have played a crucial role in driving forward their collective research efforts.

Conclusion

Jessymol Mathew's contributions to biomedicine and her ongoing work at Myriad Genetics, Inc. reflect her dedication to innovation. Her patents, particularly in the realm of neurokinin antagonists, showcase her potential to impact medical science significantly. As she continues her research, the scientific community eagerly anticipates her future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…